Haemonetics Corporation (HAE)

Current ratio

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Total current assets	US$ in thousands	768,903	769,722	756,031	693,546	603,639
Total current liabilities	US$ in thousands	300,383	251,816	442,266	253,495	274,822
Current ratio		2.56	3.06	1.71	2.74	2.20

March 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $768,903K ÷ $300,383K
= 2.56

The current ratio of Haemonetics Corporation has fluctuated over the past five years. In the most recent fiscal year ending March 31, 2024, the current ratio stands at 2.56, indicating that the company has $2.56 in current assets for every $1 in current liabilities.

Comparing this to the previous years, the current ratio was higher in the fiscal year ending March 31, 2023, at 3.06, suggesting a stronger liquidity position compared to the latest year. Conversely, in the fiscal year ending March 31, 2022, the current ratio dropped to 1.71, signifying a potential liquidity concern as the company had $1.71 in current assets for every $1 in current liabilities.

The current ratio then increased in the following year ending March 31, 2023, to 2.74, indicating an improvement in liquidity position. Subsequently, in the fiscal year ending March 31, 2020, the current ratio was 2.20, which also depicted a moderate level of liquidity.

Overall, the fluctuation in Haemonetics Corporation's current ratio over the years suggests varying levels of liquidity and the ability to meet short-term obligations. Further analysis is necessary to understand the factors driving these changes and assess the company's overall financial health.